Datasheet | February 23, 2023

Informed Decisions, Empowered Patients, And Improved Outcomes

GettyImages-851960194 econsent

Informed consent is one of the most important elements of clinical trials, but it can be a time-consuming and inconsistent process that places additional demands on valuable site staff.

In adopting electronic methods, guidance published by TransCelerate Biopharma, Inc. has indicated that if using eConsent, the platform should provide a detailed overview of the clinical trial process in the patient’s own language, while including guided instructions for completing the eConsent and allowing the patient to electronically sign and optionally download the signed consent document.

If all the boxes are checked, the technology-driven patient engagement feature can improve site/patient discussions and clinical trial efficiency. Learn more about how eConsent is offering a more reliable way to consent patients into a clinical trial.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader